Tapewire

Nasdaq · USD

ANAB

ANAPTYSBIO, INC

Export transactions ↓
Tapewire entity
4640
SEC CIK
0001370053
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 2026017
Feb 202601
Mar 2026013
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 05, 2021 Filed Nov 5, 2021 22:24 UTC
Suria HamzaDirector · President, CEO
SaleCommon Stock 14,302 $35.00 $500,570.00
Disclosure

SEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 4

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,636

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 22:24 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 14,302 $1.12 $16,018.24
Disclosure

SEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 3

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 18:23 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $20.16 $0.00
Disclosure

SEC source: 0001209191-21-063260 · doc4.xml · derivative · entry 5

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 2,500 shares

Expires 2030-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F3 · balance_after: In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 18:23 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $14.02 $0.00
Disclosure

SEC source: 0001209191-21-063260 · doc4.xml · derivative · entry 4

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,500

Underlying: Common Stock · 2,500 shares

Expires 2029-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F3 · balance_after: In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 18:23 UTC
LOUMEAU ERIC JCOO, General Counsel
SaleCommon Stock 5,000 $35.00 $175,000.00
Disclosure

SEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 18:23 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionCommon Stock 2,500 $20.16 $50,400.00
Disclosure

SEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 18:23 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionCommon Stock 2,500 $14.02 $35,050.00
Disclosure

SEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 22:24 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,059 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-21-063263 · doc4.xml · derivative · entry 5

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,302

Underlying: Common Stock · 6,059 shares

Expires 2021-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021.

F3 · balance_after: In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 22:24 UTC
Suria HamzaDirector · President, CEO
SaleCommon Stock 6,059 $35.00 $212,065.00
Disclosure

SEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 2

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,636

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 22:24 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 6,059 $1.12 $6,786.08
Disclosure

SEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2021 Filed Nov 2, 2021 21:53 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 36,646 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-21-062481 · doc4.xml · derivative · entry 4

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,645

Underlying: Common Stock · 36,646 shares

Expires 2022-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022.

F5 · balance_after: In addition to the remaining options to purchase 36,645 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.

Read SEC document
November 01, 2021 Filed Nov 2, 2021 21:53 UTC
Suria HamzaDirector · President, CEO
SaleCommon Stock 2,559 $32.88 $84,139.41
Disclosure

SEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 3

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,636

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
November 01, 2021 Filed Nov 2, 2021 21:53 UTC
Suria HamzaDirector · President, CEO
SaleCommon Stock 34,087 $32.27 $1,099,967.04
Disclosure

SEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 2

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,195

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.84 to $32.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
November 01, 2021 Filed Nov 2, 2021 21:53 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 36,646 $1.12 $41,043.52
Disclosure

SEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 23:54 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 15,993 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-21-061975 · doc4.xml · derivative · entry 3

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,291

Underlying: Common Stock · 15,993 shares

Expires 2022-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022.

F3 · balance_after: In addition to the remaining options to purchase 73,291 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 23:54 UTC
Suria HamzaDirector · President, CEO
SaleCommon Stock 15,993 $30.00 $479,790.00
Disclosure

SEC source: 0001209191-21-061975 · doc4.xml · nonDerivative · entry 2

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,636

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 23:54 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 15,993 $1.12 $17,912.16
Disclosure

SEC source: 0001209191-21-061975 · doc4.xml · nonDerivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 21:38 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-21-057077 · doc4.xml · derivative · entry 2

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,361

Underlying: Common Stock · 10,000 shares

Expires 2021-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable.

F2 · balance_after: In addition to the remaining options to purchase 20,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 21:38 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 10,000 $1.12 $11,200.00
Disclosure

SEC source: 0001209191-21-057077 · doc4.xml · nonDerivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2021 Filed May 13, 2021 20:50 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-21-032377 · doc4.xml · derivative · entry 2

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,361

Underlying: Common Stock · 10,000 shares

Expires 2021-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable.

F2 · balance_after: In addition to the remaining options to purchase 30,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 57,636 shares of common stock held directly.

Read SEC document
May 12, 2021 Filed May 13, 2021 20:50 UTC
Suria HamzaDirector · President, CEO
Exercise / conversionCommon Stock 10,000 $1.12 $11,200.00
Disclosure

SEC source: 0001209191-21-032377 · doc4.xml · nonDerivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 4, 2021 16:51 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 165,000 $23.25 $3,835,755.00
Disclosure

SEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 3

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,520,424

F4 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,374,066 shares of the Issuer's Common Stock.

F4 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,374,066 shares of the Issuer's Common Stock.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
May 03, 2021 Filed May 4, 2021 16:51 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 20,800 $23.31 $484,872.96
Disclosure

SEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,355,424

F3 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,209,066 shares of the Issuer's Common Stock.

F3 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,209,066 shares of the Issuer's Common Stock.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
April 30, 2021 Filed May 4, 2021 16:51 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 35,700 $23.16 $826,815.57
Disclosure

SEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,334,624

F2 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,188,266 shares of the Issuer's Common Stock.

F2 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,188,266 shares of the Issuer's Common Stock.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
April 27, 2021 Filed Apr 27, 2021 18:23 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 33,800 $23.82 $805,088.96
Disclosure

SEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 3

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,298,924

F2 · shares: Qualified Fund purchased all of the securities described in this transaction.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
April 26, 2021 Filed Apr 27, 2021 18:23 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 13,900 $23.80 $330,858.92
Disclosure

SEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,265,124

F2 · shares: Qualified Fund purchased all of the securities described in this transaction.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 18:23 UTC
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
PurchaseCommon Stock 99,600 $23.54 $2,344,285.20
Disclosure

SEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner

NODELMAN OLEG · CIK 0001454385 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,251,224

F2 · shares: Qualified Fund purchased all of the securities described in this transaction.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 22:53 UTC PurchaseCommon Stock 531,000 $18.70 $9,928,425.60
Disclosure

SEC source: 0001567619-21-006040 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital, LLC · CIK 0001587114 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 7,151,624

F3 · shares: Qualified Fund purchased 445,987 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund held 6,005,266 shares of Common Stock.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
March 08, 2021 Filed Mar 10, 2021 22:53 UTC PurchaseCommon Stock 2,777,800 $18.97 $52,694,310.44
Disclosure

SEC source: 0001567619-21-006040 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 6,620,624

F2 · shares: Qualified Fund purchased 2,333,073 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund held 5,559,279 shares of Common Stock.

F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
February 23, 2021 Filed Feb 25, 2021 22:58 UTC PurchaseCommon Stock 29,500 $25.48 $751,657.05
Disclosure

SEC source: 0001567619-21-004961 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital, LLC · CIK 0001587114 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Note 1

Disclosed balance after: 3,842,824

F2 · shares: Qualified Fund purchased 13,862 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund owned 3,226,206 shares of Common Stock.

F1 · ownership.nature: The filing persons (the "Filers" are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
February 12, 2021 Filed Feb 12, 2021 21:28 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $14.02 $0.00
Disclosure

SEC source: 0001209191-21-010517 · doc4.xml · derivative · entry 4

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F4 · balance_after: In addition to the remaining option to purchase 88,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 147,500 shares of common stock, which options vest according to their terms.

Read SEC document
February 12, 2021 Filed Feb 12, 2021 21:28 UTC
LOUMEAU ERIC JCOO, General Counsel
SaleCommon Stock 10,000 $35.00 $350,000.00
Disclosure

SEC source: 0001209191-21-010517 · doc4.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction reported on this Form 4 were effected pursuant to a Rule 105b-1 trading plan adopted by the reporting person.

Read SEC document
February 12, 2021 Filed Feb 12, 2021 21:28 UTC
LOUMEAU ERIC JCOO, General Counsel
Exercise / conversionCommon Stock 10,000 $14.02 $140,200.00
Disclosure

SEC source: 0001209191-21-010517 · doc4.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:24 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010512 · doc4.xml · derivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:42 UTC
Lizzul Paul F.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010533 · doc4.xml · derivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:36 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010527 · doc4.xml · derivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 12, 2021 21:28 UTC
LOUMEAU ERIC JCOO, General Counsel
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010517 · doc4.xml · derivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2031-02-09

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:26 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010513 · doc4.xml · derivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:44 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010534 · doc4.xml · derivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:27 UTC
MULROY DENNISChief Financial Officer
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010514 · doc4.xml · derivative · entry 1

MULROY DENNIS · CIK 0001276840 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:36 UTC
Topper James NDirector · 10% owner
GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010526 · doc4.xml · derivative · entry 1

Topper James N · CIK 0001341382 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:40 UTC
Hamill LauraDirector
GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010530 · doc4.xml · derivative · entry 1

Hamill Laura · CIK 0001751804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:40 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010531 · doc4.xml · derivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 10, 2021 Filed Feb 13, 2021 02:29 UTC
Suria HamzaDirector · President, CEO
GrantStock Option (right to buy) · Derivative 119,700 $0.00 Strike: $29.70 $0.00
Disclosure

SEC source: 0001209191-21-010518 · doc4.xml · derivative · entry 1

Suria Hamza · CIK 0001654495 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,700

Underlying: Common Stock · 119,700 shares

Expires 2031-02-09

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Read SEC document
January 18, 2021 Filed Jan 19, 2021 21:36 UTC GrantStock Option (right to buy) · Derivative 784 $0.00 Strike: $26.11 $0.00
Disclosure

SEC source: 0001209191-21-004027 · doc4.xml · derivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 784

Underlying: Common Stock · 784 shares

Expires 2031-01-17

F2 · derivative.exercise_date: The stock option shall be fully vested as of February 12, 2021, subject to the Reporting Person's continued service on the vesting date.

Read SEC document
January 18, 2021 Filed Jan 19, 2021 21:36 UTC GrantStock Option (right to buy) · Derivative 11,000 $0.00 Strike: $26.11 $0.00
Disclosure

SEC source: 0001209191-21-004027 · doc4.xml · derivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2031-01-17

F1 · derivative.exercise_date: The stock option vests as to 1/36 of the total shares monthly beginning on February 18, 2021 until fully vested, subject to the Reporting Person's continued service on each vesting date.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:15 UTC OtherCommon Stock 26,354 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 5

Topper James N · CIK 0001341382 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,812

F8 · kind: Shares acquired by Dr. Topper through a distribution in-kind from Frazier Healthcare VII, L.P.

F9 · balance_after: Dr. Topper also holds stock options to purchase up to an aggregate of 38,000 shares of the Issuer's Common Stock, which stock options vest according to their terms, in addition to the 80,812 shares of Common Stock that are held directly by Dr. Topper.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:15 UTC OtherCommon Stock 22,604 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 4

Topper James N · CIK 0001341382 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,458

F7 · kind: Shares acquired by Dr. Topper through a distribution in-kind from Frazier Healthcare V, L.P.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:15 UTC OtherCommon Stock 98,275 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 3

Topper James N · CIK 0001341382 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Frazier Healthcare VII-A, L.P.

Disclosed balance after: 199,529

F5 · kind: Represents a pro rata distribution in-kind by Frazier Healthcare VII-A, L.P. to its limited partners for no consideration.

F6 · ownership.nature: The reportable securities are held directly by Frazier Healthcare VII-A, L.P. FHM VII, L.P. is the general partner of Frazier Healthcare VII-A, L.P. FHM VII, L.L.C. is the general partner of FHM VII, L.P. James Topper is one of six managing members of FHM VII, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by Frazier Healthcare VII-A, L.P., except to the extent of his pecuniary interest therein, if any.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:15 UTC OtherCommon Stock 344,860 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 2

Topper James N · CIK 0001341382 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Frazier Healthcare VII, L.P.

Disclosed balance after: 700,171

F3 · kind: Represents a pro rata distribution in-kind by Frazier Healthcare VII, L.P. to its limited partners for no consideration.

F4 · ownership.nature: The reportable securities are held directly by Frazier Healthcare VII, L.P. FHM VII, L.P. is the general partner of Frazier Healthcare VII, L.P. FHM VII, L.L.C. is the general partner of FHM VII, L.P. James Topper is one of six managing members of FHM VII, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by Frazier Healthcare VII, L.P., except to the extent of his pecuniary interest therein, if any.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.